getireceine
Getireceine, also known as getirecene or 1-(4-chlorophenyl)-3-(1H-indol-3-yl)propane-1,3-dione, is a synthetic cannabinoid receptor agonist. It was first synthesized in 2012 and has since gained attention due to its potential psychoactive properties. Getireceine is structurally similar to other synthetic cannabinoids, such as JWH-018 and JWH-073, and is believed to act as an agonist at the cannabinoid type 1 (CB1) receptor, which is a type of receptor in the body that is activated by cannabinoids found in cannabis.
The psychoactive effects of getireceine are similar to those of other synthetic cannabinoids, including euphoria, relaxation,
Like other synthetic cannabinoids, getireceine is not approved for medical use and is illegal in many countries.
In summary, getireceine is a synthetic cannabinoid receptor agonist that is structurally similar to other synthetic